Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Asset Writedowns and Impairment (2019 - 2025)

Evolus filings provide 7 years of Asset Writedowns and Impairment readings, the most recent being $2.2 million for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 148.59% to $2.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.8 million, a 172.44% increase, with the full-year FY2024 number at $2.4 million, up 70.07% from a year prior.
  • Asset Writedowns and Impairment hit $2.2 million in Q3 2025 for Evolus, up from $703000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.2 million in Q3 2025 to a low of -$297000.0 in Q2 2021.
  • Median Asset Writedowns and Impairment over the past 5 years was $465000.0 (2022), compared with a mean of $528421.1.
  • Biggest five-year swings in Asset Writedowns and Impairment: crashed 76.6% in 2021 and later surged 818.6% in 2024.
  • Evolus' Asset Writedowns and Impairment stood at $88000.0 in 2021, then soared by 167.05% to $235000.0 in 2022, then plummeted by 63.4% to $86000.0 in 2023, then surged by 818.6% to $790000.0 in 2024, then skyrocketed by 179.75% to $2.2 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $2.2 million (Q3 2025), $703000.0 (Q2 2025), and $1.1 million (Q1 2025) per Business Quant data.